Background Photonumeric scales have consistently shown superiority over descriptive equivalents. They have the advantage of providing a consistent visual frame of reference by minimizing variability in perception and subjectivity. A photonumeric scale to assess hypertrophic facial photodamage already exists. However, there is currently no objective measure for atrophic facial photodamage. To address this, we have devised a nine-point photonumeric standardized scale. Objectives To design, test and validate a photonumeric scale for the assessment of atrophic facial photodamage against a descriptive scale for the same indication. Methods A pool of 393 facial photographs (en face and 45°oblique) from 131 individuals with atrophic facial photodamage was created. Five photographic standards were selected and assigned grades zero through to eight, where zero is no photodamage and eight is severe atrophic photodamage, thus making a ninepoint scale. Twenty photographs spanning the entire range of values were selected to test the scale. Testing was performed alongside a descriptive equivalent. A panel of 10 dermatologists, 10 nondermatology clinicians and 14 dermatology scientists marked the two scales; marking was repeated 1 week later. Results There was a significantly greater agreement between the graders using the photonumeric scale than the descriptive scale (kappa values 0Á71 and 0Á37 with standardized errors of 0Á57 and 0Á17, respectively) with no significant difference in repeatability between the two methods (P < 0Á05). Conclusions The study describes a new photonumeric scale for atrophic photodamage. This would be a useful adjunct in both the clinical and research settings.
Summary
Background Photonumeric scales have consistently shown superiority over descriptive equivalents. They have the advantage of providing a consistent visual frame of reference by minimizing variability in perception and subjectivity. A photonumeric scale to assess hypertrophic facial photodamage already exists. However, there is currently no objective measure for atrophic facial photodamage. To address this, we have devised a nine-point photonumeric standardized scale. Objectives To design, test and validate a photonumeric scale for the assessment of atrophic facial photodamage against a descriptive scale for the same indication. Methods A pool of 393 facial photographs (en face and 45°oblique) from 131 individuals with atrophic facial photodamage was created. Five photographic standards were selected and assigned grades zero through to eight, where zero is no photodamage and eight is severe atrophic photodamage, thus making a ninepoint scale. Twenty photographs spanning the entire range of values were selected to test the scale. Testing was performed alongside a descriptive equivalent. A panel of 10 dermatologists, 10 nondermatology clinicians and 14 dermatology scientists marked the two scales; marking was repeated 1 week later. Results There was a significantly greater agreement between the graders using the photonumeric scale than the descriptive scale (kappa values 0Á71 and 0Á37 with standardized errors of 0Á57 and 0Á17, respectively) with no significant difference in repeatability between the two methods (P < 0Á05). Conclusions The study describes a new photonumeric scale for atrophic photodamage. This would be a useful adjunct in both the clinical and research settings.
What's already known about this topic?
• Photonumeric scales demonstrate consistent superiority when compared with descriptive equivalents.
• Hypertrophic facial photodamage has been assessed successfully in terms of both severity and treatment response using a well-established photonumeric scale.
What does this study add?
• A new photonumeric scale created and validated for the assessment of a newly recognized clinical phenotype of facial photodamage -atrophic photodamage.
It has been long established that photodamage or extrinsic ageing is a largely preventable and treatable entity that is readily distinguishable from chronological or intrinsic ageing.
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What is less well-established is the diagnosis and evaluation of extrinsic ageing, a skill not traditionally taught among dermatologists. In fact, photodamage often goes unrecognized clinically, and thus is misdiagnosed as accelerated or severe intrinsic ageing. Furthermore, it has only recently been recognized that more than one form of facial photodamage exists among individuals with lightly pigmented skin (Fitzpatrick phototypes I-III; previously termed 'Caucasian'). 3, 4 The clinical assessment of photodamage requires a subjective evaluation of characteristic features, and has been influenced by interobserver differences in grading criteria. 5 The assessment is often based upon a visual and tactile inspection of the skin, and an evaluation of generalized characteristic features such as fine and coarse wrinkling, pigmented lesions, colour, roughness and telangiectasia. 6, 7 In 1992, a photonumeric tool was developed for the assessment of a specific subgroup of photodamage termed 'hypertrophic photodamage'. 8 Hypertrophic facial photodamage encompasses thick coarse wrinkling and skin laxity, a leathered and rough skin texture with elastoidosis, dyspigmentation and often solar comedones as seen in Favre-Racouchot syndrome. 9 However, a second subgroup of facial photodamage has now been described in which individuals have thin, shiny, glossy, atrophic skin with telangiectasia, minimal wrinkling and an increased frequency of actinic keratoses and keratinocyte cancers. 10, 11 This is termed 'atrophic photodamage'. A photonumeric scale developed for the assessment of increasing severity of atrophic facial photodamage has not thus far been published in the literature. This is primarily because atrophic facial photodamage has only very recently been characterized in the literature. The purpose of developing such a scale for this indication is twofold: (i) this phenotype denotes an increased susceptibility to the development of keratinocyte carcinoma, 11 thus it is important for clinicians to be able to recognize it clinically; and (ii) as with all forms of photodamage, it is readily preventable. Descriptive scales have historically proven to be less userfriendly and a poorer assessment tool for photodamage. Numerous photonumeric scales are published in the literature, each with a specific focus on different aspects of skin disease; photodamage and its constituents is no exception. [12] [13] [14] The photonumeric scale for hypertrophic cutaneous facial photodamage 8 is perhaps the best example. We have produced a similar photonumeric grading system to assess atrophic cutaneous facial photodamage. The resulting scale is based on high-quality photographic standards and was tested for both intergrader and intragrader agreement.
Patients and methods
Local ethical approval was obtained from the Greater Manchester Central NHS Research Committee (research ethics committee reference 13/NW/0723). Written informed consent was obtained from the volunteers and the study adhered to Declaration of Helsinki principles. In total, 131 volunteers took part in the study (71 men; 60 women; age range 54-98 years). All volunteers selected for the study were classified as Fitzpatrick sun reactive skin types I-III. In total, 393 facial photographs were taken with a Cannon EOS D30 camera (en face and 45°oblique; Canon, Lake Success, NY, U.S.A.), of 131 individuals with atrophic photodamage presenting to outpatient dermatology departments in Salford Royal NHS Foundation Trust and East Cheshire Trust, U.K. Each participant was photographed against a black backdrop and wore a dark drape with their hair removed from sight where appropriate by use of a headband to avoid obscuring the face. From this pool, nine photographic standards were selected as representative examples of atrophic photodamage and assigned grades zero through to eight, thus making a nine-point scale where zero is no photodamage and eight is severe atrophic photodamage (Fig. 1) . A further 20 photographs were selected that were thought to best represent and span the entire range of values.
The standards were selected for their ability to portray the nontactile and easily photographable factors of atrophic photodamage, that is, thin, shiny, telangiectatic skin, adequately. A pilot study was performed by P.B. and E.D.-P. using selected photographic anchors. The results of the pilot study were used to determine which photographic standards were selected for the photonumeric scale.
To test the agreement and repeatability of the photonumeric scale, it was compared with a descriptive scale developed for this study, as there was no conventional descriptive written scale in existence for the grading of atrophic skin. The descriptive scale used the following parameters: telangiectasia, skin thinning and fragility, glossy skin texture and skin smoothness. Each of these parameters could have a score assigned between zero and two; zero being absent, one being mild and two being severe. This allowed a rater to assign a minimum score of zero and a maximum score of eight.
Agreement, in this context, is the degree to which the grader gave the test photographs a score identical to that which has already been assigned to the image. Repeatability, however, refers to the ability of each grader to reproduce exactly that original score at a subsequent time, having allowed enough time to elapse so that memory is not a likely factor. The time between each grading session was 1 week.
The grading panel was split into three groups: 10 dermatologists (senior registrars and consultants); 10 clinicians trained in specialties other than dermatology; and 14 dermatology scientists (expert in skin biology but not formally clinically trained). The panel graded the 20 photographs using the photonumeric scale and the descriptive scale alongside one another. Upon grading the same images a week later, the order of the photographs was randomized to reduce the chances of the respondents' memories affecting the results further. An exemplar photograph was included with the graders' responses (Fig. 2) .
Results
When analysing the raw data (Table 1) , there was more agreement between graders' scores when the photonumeric scale (55%) was used compared with the descriptive scale (30%). Cohen's kappa scores for the photonumeric and descriptive scale were calculated and demonstrated the reliability of the photonumeric scale over the descriptive scale; the kappa values were 0Á71 and 0Á37 with a standardized error of 0Á57 and 0Á17, respectively (P < 0Á05; Table 2 ). These results indicate substantial interobserver agreement among graders using the photonumeric scale compared with only fair agreement among graders using the descriptive scale. Repeatability of the photonumeric scale was demonstrated by a paired Student's t-test, with no significant difference between the graders taken at the two-time points (coefficient of variance of 9Á02%).
Discussion
Results of this study indicate that application of a newly devised, nine-point photographic scale results in consistent and reproducible clinical evaluations of overall photodamage severity. We have developed a new photonumeric scale for the assessment of atrophic facial photodamage. Comparing the descriptive and photonumeric scales, it became apparent that specialist dermatology training increases the interobserver agreement of both the photonumeric and descriptive scales. This could explain why the dermatology scientists overall performed better and more consistently with their rating and use of the scales compared with nondermatology doctors. Although dermatology scientists are not explicitly taught dermatology clinical skills, they work closely with dermatologists and thus will have more exposure in this field. The nondermatology clinicians had the poorest repeatability of any group, which may be explained by their reduced experience managing photodamage.
The interobserver agreement was greater with the photonumeric scale across all groups. The percentage of images with more than half of graders in agreement with the score was higher when the photonumeric scale was used. This was greatest with dermatologists, where 70% of photographs had at least half of the graders in agreement using the photonumeric scale, compared with 40% with the descriptive scale. Nondermatology clinicians (30% vs. 15%) and dermatology scientists (65% vs. 35%) consistently demonstrated the superiority of the photonumeric scale over the descriptive equivalent. This study set demonstrates the superior interobserver agreement of a photonumeric atrophic scale (Cohen's kappa 0Á71) compared with the written descriptive scale (Cohen's kappa 0Á37) for the assessment of photodamaged facial skin. The nine photographic standards of en face and 45°facial views provide an easy-to-use evaluation system for the clinician involved in the assessment and treatment of photodamaged skin.
The demonstration that this photonumeric scale is a reliable tool in the assessment of photodamage allows its use for a variety of indications. Individuals with atrophic photodamage are more prone to developing keratinocyte cancers. Identification and classification of atrophic photodamage could be important for monitoring at-risk patients and could prevent the increasing number of cases of keratinocyte carcinoma. Also, this photonumeric scale has the potential to aid with epidemiological studies of skin ageing in different countries and climates as the results have greater inter-and intraobserver repeatability across different graders than a descriptive scale.
The photonumeric scale demonstrates superiority and can be used outside clinical settings. It has a role in categorizing groups of individuals with photodamage prior to treatment with skin repair agents, thereby obtaining consistent and uniform groupings of patients, for example, those with mild to severe photodamage. This would allow greater reliability among centres involved in photodamage studies and enable independent re-grading of good-quality study photographs.
In conclusion, this new nine-point photographic scale, which shows strong repeatability and reproducibility, should be useful in categorizing individuals with atrophic photodamage in epidemiological studies where photodamage severity is either studied, or thought to be a factor in the relevant end point. The scale will also be useful in characterizing individuals with atrophic photodamage entering clinical trials for treatment of photodamage or for conditions where atrophic photodamage severity is a relevant cofactor. Cohen's kappa coefficient, identifies the superiority of the photonumeric over the descriptive scale.
